Chromadex Corp Stock
Chromadex Corp Stock
A loss of -1.800% shows a downward development for Chromadex Corp.
Chromadex Corp is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
With a target price of 10 € there is a hugely positive potential of 83.49% for Chromadex Corp compared to the current price of 5.45 €.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -1.800% | 0.000% | -4.310% | -4.310% | 7.767% | 271.113% | 32.143% |
| Intellia Therapeutics Inc | 0.030% | -6.699% | 2.753% | -37.471% | -32.354% | -78.838% | -82.083% |
| Cardio3 Biosciences S.A. | -11.080% | -4.464% | -9.577% | -76.739% | -75.719% | -82.186% | -97.597% |
| Polynovo Ltd | -2.210% | 0.758% | 5.556% | -45.041% | -45.041% | -48.047% | -71.581% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat